These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 32739907)
61. Is afamin a potential early biomarker for subsequent development of preeclampsia? A nested case-control study. Çalışkan CS; Celik S; Avcı B J Matern Fetal Neonatal Med; 2021 Jun; 34(12):2006-2011. PubMed ID: 33028116 [TBL] [Abstract][Full Text] [Related]
62. Placental HtrA3 is regulated by oxygen tension and serum levels are altered during early pregnancy in women destined to develop preeclampsia. Li Y; Puryer M; Lin E; Hale K; Salamonsen LA; Manuelpillai U; Tong S; Chan W; Wallace EM; Nie G J Clin Endocrinol Metab; 2011 Feb; 96(2):403-11. PubMed ID: 21047919 [TBL] [Abstract][Full Text] [Related]
63. Predictive Role of First-trimester ELABELA Levels for Late-onset Preeclampsia. Ozgen G; Aydin GA; Ayvaci H J Coll Physicians Surg Pak; 2021 Aug; 31(8):916-920. PubMed ID: 34320707 [TBL] [Abstract][Full Text] [Related]
64. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE. Tan MY; Poon LC; Rolnik DL; Syngelaki A; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright D; Nicolaides KH Ultrasound Obstet Gynecol; 2018 Jul; 52(1):52-59. PubMed ID: 29704277 [TBL] [Abstract][Full Text] [Related]
65. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Giudice LC; Martina NA; Crystal RA; Tazuke S; Druzin M Am J Obstet Gynecol; 1997 Apr; 176(4):751-7; discussion 757-8. PubMed ID: 9125598 [TBL] [Abstract][Full Text] [Related]
66. Bioinformatics approach reveals evidence for impaired endometrial maturation before and during early pregnancy in women who developed preeclampsia. Rabaglino MB; Post Uiterweer ED; Jeyabalan A; Hogge WA; Conrad KP Hypertension; 2015 Feb; 65(2):421-9. PubMed ID: 25421975 [TBL] [Abstract][Full Text] [Related]
68. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Tidwell SC; Ho HN; Chiu WH; Torry RJ; Torry DS Am J Obstet Gynecol; 2001 May; 184(6):1267-72. PubMed ID: 11349200 [TBL] [Abstract][Full Text] [Related]
69. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826 [TBL] [Abstract][Full Text] [Related]
70. Serum Follistatin-like-3 was elevated in second trimester of pregnant women who subsequently developed preeclampsia. Han X; He J; Wang A; Dong M Hypertens Pregnancy; 2014 Aug; 33(3):277-82. PubMed ID: 24475769 [TBL] [Abstract][Full Text] [Related]
71. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study. Keikkala E; Koskinen S; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH BMC Pregnancy Childbirth; 2016 Nov; 16(1):378. PubMed ID: 27887594 [TBL] [Abstract][Full Text] [Related]
72. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester]. Ye YH; Liu L; Zhan Y; Peng W Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803 [TBL] [Abstract][Full Text] [Related]
73. Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia. Lai J; Syngelaki A; Poon LC; Nucci M; Nicolaides KH Fetal Diagn Ther; 2013; 33(3):149-55. PubMed ID: 23154616 [TBL] [Abstract][Full Text] [Related]
74. Combination of NGAL and Cystatin C for Prediction of Preeclampsia at 10-14 Weeks of Gestation. Zhang HB; Fan JM; Zhu LL; Yuan XH; Shen XW Clin Lab; 2019 May; 65(5):. PubMed ID: 31115219 [TBL] [Abstract][Full Text] [Related]
75. Serum hyperglycosylated human chorionic gonadotrophin at 14-17 weeks of gestation does not predict preeclampsia. Keikkala E; Ranta JK; Vuorela P; Leinonen R; Laivuori H; Väisänen S; Marttala J; Romppanen J; Pulkki K; Stenman UH; Heinonen S Prenat Diagn; 2014 Jul; 34(7):699-705. PubMed ID: 24464955 [TBL] [Abstract][Full Text] [Related]
76. Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models. Murtoniemi K; Villa PM; Matomäki J; Keikkala E; Vuorela P; Hämäläinen E; Kajantie E; Pesonen AK; Räikkönen K; Taipale P; Stenman UH; Laivuori H BMC Pregnancy Childbirth; 2018 Jul; 18(1):279. PubMed ID: 29970026 [TBL] [Abstract][Full Text] [Related]
78. Distinct First Trimester Cytokine Profiles for Gestational Hypertension and Preeclampsia. Tangerås LH; Austdal M; Skråstad RB; Salvesen KÅ; Austgulen R; Bathen TF; Iversen AC Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2478-85. PubMed ID: 26404486 [TBL] [Abstract][Full Text] [Related]
79. Predictive Value of Maternal Serum Biomarkers for Preeclampsia and Birth Weight: A Case-Control Study in Chinese Pregnant Women. Sun LJ; Xu GF; Lv M; Zhou H; Huang HF; Luo Q J Womens Health (Larchmt); 2018 Dec; 27(12):1519-1524. PubMed ID: 29920141 [TBL] [Abstract][Full Text] [Related]
80. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]